Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US

References

• British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax 2001;56(Suppl. 4):IV1-64
   PubMed Web of Science ®Google Scholar
• Birnbaum HG, Morley MA, Greenberg PE, et al. Economic burden of pneumonia in an employed population. Arch Intern Med 2001;161:2725-31
   PubMed Web of Science ®Google Scholar
• Kaplan V, Angus DC, Griffin MF, et al. Hospitalized community-acquired pneumonia in the elderly. Age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002;165:766-72
   PubMed Web of Science ®Google Scholar
• Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996;275:134-41
   PubMed Web of Science ®Google Scholar
• Kozak LJ, DeFrances CJ, Hall MJ. National Hospital Discharge Survey: 2004 annual summary with detailed diagnosis and procedure data. National Center for Health Statistics. Vital Health Stat 2006;13:1-209
   Google Scholar
• Goss CH, Rubenfeld GD, Park DR, et al. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital. Chest 2003;124:2148-55
   PubMed Web of Science ®Google Scholar
• Lave JR, Lin CJ, Fine MJ, et al. The cost of treating patients with community-acquired pneumonia. Semin Respir Crit Care Med 1999;20:189-97
   Web of Science ®Google Scholar
• Dean NC, Suchyta MRB, Bateman KA, et al. Implementation of admission decision support for community-acquired pneumonia. A Pilot Study. Chest 2000;117:1368-77
   Google Scholar
• Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54
   PubMed Web of Science ®Google Scholar
• Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-33
   PubMed Web of Science ®Google Scholar
• Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50
   PubMed Web of Science ®Google Scholar
• Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82
   PubMed Web of Science ®Google Scholar
• Johnstone J, Majumdar SR, Marrie TJ. The value of prognostic indices for pneumonia. Curr Infect Dis Rep 2008;10:215-22
   PubMedGoogle Scholar
• Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005;118:384-92
   PubMed Web of Science ®Google Scholar
• Spindler C, Ortqvist A. Prognostic score systems and communityacquired bacteraemic pneumococcal pneumonia. Eur Respir J 2006;28:816-23
   PubMed Web of Science ®Google Scholar
• Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000;283:749-55
   PubMed Web of Science ®Google Scholar
• Fine MJ, Pratt HM, Obrosky DS, et al. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med 2000;109:378-85
   PubMed Web of Science ®Google Scholar
• McCormick D, Fine MJ, Coley C, et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?. Am J Med 1999;107:5-12
   PubMed Web of Science ®Google Scholar
• Schein J, Janagap-Benson C, Grant R, et al. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Curr Med Res Opin 2008;24:895-906
   PubMed Web of Science ®Google Scholar
• Colice GL, Morley MA, Asche C, et al. Treatment costs of community-acquired pneumonia in an employed population. Chest 2004;125:2140-5
   PubMed Web of Science ®Google Scholar
• Annual Estimates of the Population for the United States, Regions, States, and Puerto Rico: April 1, 2000 to July 1, 2007 (NST-EST2007-01). Available at: http://www.census.gov/popest/states/NST-ann-est.html [Last accessed 2 August 2008]
   Google Scholar
• Centers for Disease Control and Prevention. Premature Deaths, Monthly Mortality, and Monthly Physician Contacts – United States. MMWR Morb Mortal Wkly Rep 1997;46:556-61
   PubMedGoogle Scholar
• DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. National Center for Health Statistics. Vital Health Stat 2007;165:1-209
   Google Scholar
• U.S. Department of Labor. Bureau of Labor Statistics. CPI Inflation Calculator. Available at: http://www.bls.gov/data/inflation_calculator.htm (Last accessed June 29, 2009)
   Google Scholar
• Orrick JJ, Segal R, Johns TE, et al. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to Infectious Diseases Society of America guidelines. Pharmacoeconomics 2004;22:751-7
   PubMed Web of Science ®Google Scholar
• Whittle J, Lin CJ, Fine MJ, et al. Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia. Med Care 1998;36:977-87
   PubMed Web of Science ®Google Scholar
• Niederman MS, McCombs JS, Unger AN, et al. The cost of treating community-acquired pneumonia. Clin Ther 1998;20:820-837
   PubMed Web of Science ®Google Scholar